top of page
Supported projects
OMIOS Biological
US-based biotech developing the first biomarker-guided, non-attenuated oncolytic virus platform engineered for systemic intravenous delivery and selective replication in cancer cells.
PSCC's entrance
June 2026
Localization
USA - California
Modality
Vaccine
Development status
Biotech - Lead optimization
Award(s)
bottom of page